Citations

Clear

4847 citation(s) found for "Tu, Eric".

Interpretable variant effect prediction from genomic foundation model representations
Pearce, Michael T, Dooms, Thomas , Yamamoto, Ryō , Ayanian, Shant , Ryu, Alexander J. , Meehl, Joshua , Molnar, Carl , Kiiskinen, Tuomo , Bissell, Mark, Hazra, Dron , Fang, Ching, Nguyen, Nam, Anderson, Michael, Osborne, Collin , Toomey, Bridget , Klee, Eric W. , Korfiatis, Panagiotis , Redlon, Matt , Jain, Archa , Balsam, Daniel, Wang, Nicholas K. , Pearce, Michael T., Dooms, Thomas, Ryu, Alexander J. , Duffy, Patrick Emmet , Myasoedova, Elena

Mayo Clinic

No container title available | April 12, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.04.10.717844 Get It

Abstract Scientific foundation models learn high-dimensional representations from diverse data modalities, yet what they encode and how to extract that knowledge remain open questions. Here we show that probing the internal representations of Evo 2, a 7-billion-parameter genomic foundation model, enables accurate and interpretable genetic variant effect prediction. We introduce a covariance-based probe that captures second-order structure from Evo 2 sequence embeddings to predict variant pathogenicity across variant types and functional consequences, matching or exceeding specialized predictors within their domains. To ground these predictions in known biological mechanisms, we train a complementary panel of probes on existing annotations to detect which genomic properties are disrupted by a variant. This categorized evidence is then integrated with each variant’s genomic context through a language model to generate variant-specific mechanistic hypotheses. Our pathogenicity predictions correlate with experimental measures of variant function, clinical penetrance, and biobank disease associations while the mechanistic hypotheses are consistent with expert reviews, known mechanism classes, and downstream molecular readouts. We release pathogenicity scores, disruption profiles, and contextualized interpretations for 4.2 million variants from the ClinVar database as an open resource through the Evo Variant Effect Explorer (EVEE). More broadly, this structured probing approach offers a general framework for interrogating foundation models across scientific disciplines and grounding their outputs in existing domain concepts.
CNS tumor type prevalence according to age group: An analysis of 21 000 cases confirmed by methylation profiling, with a focus on adolescents and young adults
Fonseca, Adriana , Yefet, Leeor, Singh, Omkar , Dampier, Christopher H. , Dazelle, Karen , Lam, Michelle , Abdullaev, Zied , Chung, Hye‐Jung, Quezado, Martha, Raffeld, Mark , Lee, Ina, Nasrallah, MacLean, Bennett, Julie, Bouffet, Eric, Poria, Dipak, Wesseling, Pieter, Bent, Martin van den, Wen, Patrick Y, Varlet, Pascale, Tauziède-Espariat, Arnault, Zadeh, Gelareh, Aldape, Kenneth, Singh, Omkar , Dampier, Christopher H , Quezado, Martha , Gagan, Jeffrey , Lee, Ina , Nasrallah, MacLean , Bennett, Julie , Bouffet, Eric , Poria, Dipak , Wesseling, Pieter , van den Bent, Martin J , Wen, Patrick Yung , Varlet, Pascale , Tauziède-Espariat, Arnault , Ida, Cristiane M , Zadeh, Gelareh , Aldape, Kenneth , Yefet, Leeor S. , Gagan, Jeffrey , Nasrallah, MacLean P. , Bouffet, Éric , Wesseling, Pieter , Bent, Martin J. van den , Ida, Cristiane M. , Zadeh, Gelareh

Mayo Clinic

Neuro-Oncology | April 11, 2026 | Volume: 28 | Issue: 7 | Pages: 1808-1820

10.1093/neuonc/noag082 | PMID 41978543 Get It

Abstract Background Approximately 12 000 adolescents and young adults (ages 15-39, AYAs) are diagnosed with a primary central nervous system (CNS) tumor each year. DNA methylation profiling has transformed CNS tumor classification by refining diagnostic accuracy and identifying biologically distinct subtypes, but its application has not been systematically evaluated in the AYA population. In this study, we examined the spectrum of CNS tumor types across age groups, with a focus on the AYA population. Methods We assembled a large dataset of CNS tumor samples with age annotations and methylation profiles matching with high confidence to a CNS tumor type using the NCI/Bethesda classifier. Prevalence of tumor type, methylation class and DNA copy number aberrations were compared across age strata (pediatric, AYA, and adult). Results The cohort of 21 712 CNS tumors included 5351 tumors from AYAs (25%), which showed a mixed pattern, with tumors typical of childhood (eg, medulloblastoma) as well as those common in older adults (eg, glioblastoma). Several tumor types were specifically enriched in the AYA, including IDH-mutant astrocytoma, pleomorphic xanthoastrocytoma, posterior fossa group B ependymoma, and diffuse hemispheric glioma, H3 G34-mutant, among others. Distinct methylation subclasses of multiple tumor types were observed in the AYA, and patterns of genomic aberrations showed age-specific distributions. Conclusion Large-scale methylation profiling revealed unique classification patterns of CNS tumors in AYAs, with specific tumor types, subclasses, and genomic alterations enriched in this population. These data may serve as a valuable reference resource for better understanding the spectrum of CNS tumors affecting AYA patients.
Diagnosis and management of immune effector cell–associated enterocolitis after ciltacabtagene autoleucel
Lim, Kenneth J C , Lee, Hee Eun , Chen, Zongming Eric, Bledsoe, Adam C. , Parrondo, Ricardo , Chhabra, Saurabh , Dooley, Katharine , Corraes, Andre De Menezes Silva , Gertz, Morie A. , Hwa, Y., Stephens, Haily, Kapoor, Prashant , Tan, Melinda S.Y., Kourelis, Taxiarchis , Warsame, Rahma , Yadav, Udit , Wiedmeier-Nutor, Julia Erin, Geyer, Susan, Kumar, Shaji , Chowla, Navreet , Lin, Y., Bledsoe, Adam C , De Menezes Silva Corraes, Andre , Gertz, Morie A , Hwa, Lisa, Cook, Joselle M , Binder, Moritz , Bergsagel, P. Leif , Yadav, Udit , Wiedmeier-Nutor, Erin, Fonseca, Rafael , Kumar, Shaji K , Chowla, Navreet , Parrondo, Ricardo D , Chhabra, Saurabh , Lim, Kenneth J C , Stephens, H. J. B., Cook, Joselle , Binder, Moritz , Bergsagel, P. Leif , Geyer, Susan M. , Ailawadhi, Sikander , Fonseca, Rafaël

Mayo Clinic

Blood Advances | April 10, 2026 | Volume: 10 | Issue: 13 | Pages: 4495-4507

10.1182/bloodadvances.2025018853 | PMID 41961998 Get It

Abstract Immune effector cell–associated enterocolitis (IEC-EC) has been observed after ciltacabtagene autoleucel (cilta-cel [Carvykti]) chimeric antigen receptor T-cell (CAR-T) therapy. It is associated with dismal outcomes and is poorly characterized. Here, we examined its clinical features, risk factors, and proposed management strategies. Among the 229 consecutive patients who received cilta-cel at Mayo Clinic, 9 (3.9%) presented with a nonresolving, nonbloody, grade 3 diarrhea, often requiring prolonged total parenteral nutrition. Gastrointestinal coinfections were seen in most patients. Median time from CAR-T infusion to symptom onset was 85 days (range, 35-166), and there appeared to be a latency from symptom onset to endoscopic evaluation. Histopathology findings resembling a graft-versus-host disease pattern of mucosal injury were most seen on duodenal biopsies, whereas 2 cases had patterns akin to a T-cell lymphoproliferative disorder (1 CD4+ and 1 CD8+). Independent associated factors for IEC-EC included high-risk disease as defined by the International Myeloma Society and International Myeloma Working Group, prolonged cytokine release syndrome, and antecedent delayed neurotoxicity. Response to first-line therapy comprising IV or oral corticosteroids, bile acid sequestrants, IV immunoglobulin, and antimicrobial-directed therapy was poor, with no durable responses. Biologic therapy appeared to induce durable responses in 3 of the 5 patients (2/2 vedolizumab; 1/3 infliximab); none of the responders had gastrointestinal coinfection. Early gastroenterology input for endoscopic evaluation with the inclusion of duodenal biopsy is a key component for diagnosis. Early institution of biologic therapy after failure of a short course of corticosteroids should be considered.
Effect of Cognitive Reserve on Age at Symptom Onset and Cognitive Decline in Individuals With Dominantly Inherited Alzheimer Disease
Llibre‐Guerra, Jorge J. , Lu, Ruijin , Clarens, Ma. Florencia, Liu, Ian, Renton, Alan, Ryan, Natalie S. , Goate, Alison , Aguillón, David , Benzinger, Tammie L.S. , Chhatwal, Jasmeer P. , Chrem-Méndez, Patricio , Vigo, Gabriela , Farlow, Martin R., Huey, Edward D. , Perrin, Richard J. , Wang, Guoqiao, Li, Yan, Xiong, Chengjie, Daniels, Alisha , Goate, Alison M , Benzinger, Tammie L S , Berman, Sarah , Chhatwal, Jasmeer , Chrem Mendez, Patricio , Vigo, Gabriela , Cruchaga, Carlos , Day, Gregory S , Fox, Nick C , Gordon, Brian A , Hassenstab, Jason , Huey, Edward D , Ibanez, Laura , Ikeuchi, T , Jucker, Mathias , Lee, Jae‐Hong , Levey, Allan I , Xiong, Chengjie , Niimi, Yoshiki , Perrin, Richard , Rosa-Neto, Pedro , Sánchez-Valle, Raquel , Schofield, Peter R , Morris, John C , Karch, Celeste M , Daniels, Alisha , McDade, Eric M , Bateman, Randall J , Llibre-Guerra, Jorge J , Aguillon, David , Clarens, María Florencia , Renton, Alan , Allegri, Ricardo , Berman, Sarah , Day, Gregory S. , Farlow, Martin R. , Fox, Nick C. , Gordon, Brian A. , Hassenstab, Jason , Ikeuchi, Takeshi , Levey, Allan I. , Xiong, Chengjie , Sánchez‐Valle, Raquel , Schofield, Peter R. , Wang, Guoqiao , Li, Yan , Xiong, Chengjie , Morris, John C. , Karch, Celeste M. , McDade, Eric , Bateman, Randall J.

Mayo Clinic

Neurology | April 8, 2026 | Volume: 106 | Issue: 8 | Pages: No page available

10.1212/wnl.0000000000214804 | PMID 41950468 Get It

Efficacy and safety of aspirin for primary prevention in adults with elevated lipoprotein(a) or genetic susceptibility via LPA gene variants: a systematic review and meta-analysis
Lopes, Rodolfo Alves, Vergara‐Sanchez, Carlos , TEJEDA, ALFREDO PEREZ TAGLE, Khorsandi, Jordan , Fukunaga, Christian Ken , Katsuyama, Eric , Talavera, Juan Armando , Yang, Eugene , Shapiro, Michael D. , Yang, Eugene , Lopes, Rodolfo A , Vergara Sanchez, Carlos A , Perez Tagle Tejeda, Alfredo , Ken Fukunaga, Christian , Shapiro, Michael D

Mayo Clinic

European Journal of Preventive Cardiology | April 8, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1093/eurjpc/zwag207 | PMID 42138694 Get It

Abstract Aims Routine aspirin use for primary prevention yields modest cardiovascular benefit but increases bleeding risk in average-risk adults. Whether individuals with elevated lipoprotein(a) [Lp(a)] levels or high-risk LPA variants derive greater benefit remains uncertain. Methods and results Following Cochrane and PRISMA guidelines, we systematically searched PubMed/MEDLINE, Embase, and Cochrane Central for studies of adults without ASCVD, elevated Lp(a) (≥50 mg/dL), high-risk LPA genotypes, or elevated genetic risk scores, comparing aspirin vs. no aspirin use. Random-effects meta-analyses using restricted maximum-likelihood (REML) estimation with Hartung–Knapp–Sidik–Jonkman (HKSJ) adjustment were used to pool hazard ratios (HR) and 95% confidence intervals (CI). In six studies, 6628 participants were included. Pooled random effects showed no significant reduction in major adverse cardiovascular events (MACE) with aspirin (HR = 0.60; 95% CI 0.31–1.17; P = 0.1) or clinical bleeding events (HR = 1.24; 95% CI 0.83–1.87; P = 0.18). Subgroup analyses showed a nonsignificant reduction MACE among elevated Lp(a) (HR = 0.63; 95% CI 0.16 to 2.49; P = 0.284) and statistically significant reduction among LPA rs3798220 carriers (HR = 0.37; 95% CI 0.19 to 0.71; P = 0.003), though this finding was not consistent in the sensitivity analyses. Conclusion Among adults without ASCVD but with elevated Lp(a) or high-risk LPA genotypes, aspirin use did not confer a statistically significant cardiovascular benefit and was associated with numerically higher bleeding risk. The apparent reduction seen in rs3798220 carriers was inconsistent and likely reflects small-sample bias.
Induction Cisplatin, Docetaxel, and 5-Fluorouracil Versus Platinum Doublet in Human Papillomavirus-Associated Oropharyngeal Cancer
Ganti, Ashwin , McGarrah, Patrick W. , Bayne, H. Fuentes, Fazer-Posorske, Casey , Baral, Binav, Ma, Daniel J., Neben-Wittich, M.A. , Wilson, Jessica , Moore, Eric J., Tasche, Kendall K. , Abel, Katie M. Van, Foster, Nathan R. , Price, Katharine A. , Daniel, J. , Fuentes, Harry E , Fuentes, Harry E , Baral, Binav , Ma, Daniel , Lester, Scott C. , Neben-Wittich, Michelle A, Wilson, Jessica M , Van Abel, Katie M, Price, Katharine A R , McGarrah, Patrick , Routman, David M. , Price, Daniel L. , Moore, Eric J. , Abel, Katie M. Van, Yin, Linda X.

Mayo Clinic

Viruses | April 8, 2026 | Volume: 18 | Issue: 4 | Pages: 446

10.3390/v18040446 | PMID 42043235 Get It

Management of locoregionally advanced human papillomavirus-positive oropharyngeal squamous cell carcinoma (HPV(+) OPSCC) can include induction chemotherapy followed by definitive chemoradiation. The standard induction regimen of cisplatin, docetaxel, and 5-fluorouracil (TPF) is associated with high toxicity. Given the chemosensitivity of HPV(+) OPSCC, platinum doublets are frequently used as induction therapy with potentially less toxicity. This retrospective study aimed to compare outcomes between treatment-naive HPV(+) OPSCC patients receiving induction TPF and those receiving an induction platinum doublet. Data collected included tumor characteristics, response after chemoradiation, hospitalization rates, and overall survival (OS). Fifty-five patients (18 TPF and 37 platinum doublet) were included. There was no significant difference in response after completion of definitive chemoradiation (TPF: CR 83.3%, PR 5.6%, progression or metastasis 11.1% vs. platinum doublet: CR 75.7%, PR 16.2%, progression or metastasis 8.1%; p = 0.5241). There were also no differences in hospitalizations for adverse events (38.9% in TPF vs. 40.5% in platinum doublet, p = 0.907) or recurrence (11.1% in TPF vs. 2.7% in platinum doublet, p = 0.198). The 5-year OS was 84.6% in the TPF group and 81.5% in the platinum doublet group (p = 0.581). Induction platinum doublet regimens offer comparable OS, response, and hospitalization rates to TPF in locally advanced HPV(+) OPSCC. Induction with a platinum doublet may be a viable de-escalation strategy for patients who are not candidates for TPF.
Toward actionable interventions in human aging (12th ARDD meeting, 2025)
Dekan, Aleksandr , Lore, Sierra , Yoon, Ye Eun, Sjöholm, Aisyah, Terskikh, Alexey V. , Cuervo, A. M., Georgievskaya, Anastasia , Heinz, Andrea , Adams, Andrew, Tsai, Andy P. , Murray, Anna, Brunet, Anne , Harten, Anne Marije van, Spier, Avi, Shenhar, Ben , Clasen, Berthil, Volbracht, Christiane , Kuppe, Christoph, Cookson, Clive, Banila, Cristiana , Cai, Daisy, Lamming, Dudley W. , Rudnic, Edward, Samra, Elias Bou , Verdin, Eric, Fagagna, Fabrizio d’Adda di, Zmudze, Garri, Jasper, Heinrich, Jang, In Hwa, Lemaitre, J. M., Betts-LaCroix, Joe , Newman, John C. , Kawamura, Kazuto , Schaal, Kennedy Matsagas, Egerton, Kitsu, Fortney, Kristen , Hartenstein, Lars, Niedernhofer, Laura, Katsimpardi, Lida , Melton, Lisa , Ferrucci, Luigi, Sylow, Lykke, Demaria, Marco , Guasch-Ferré, Marta, Borch-Jensen, Martin, Kholin, Maxim, Antonov, Michael, Deleidi, Michela , Mérad, Miriam , Meldal, Morten, Topors, Mourad, Venkatesan, Murali, LeBrasseur, Nathan K., Anzinger, Niklas, Fedichev, Peter O, Kohlhaas, Paul, Mullen, Peter J., Singhal, Priya , Cabo, Raquel, Montgomery, Rusty L. , Rosenzweig-Lipson, Sharon, Jakimov, Sergey, Austad, Steven N. , White, Todd, Zuber, Tom, Rozmaric, Tomaz , Wyss-Coray, Tony, Gladyshev, Vadim N., Sinatti, Vanessa V. C., Wang, Weilan, Harborne, William, Wang, Xing Li, Suh, Yousin , Lee, Y., Koch, Zane, Scheibye-Knudsen, Morten, Niedernhofer, Laura J. , Wyss‐Coray, Tony , Niedernhofer, Laura J , Lamming, Dudley W , Deleidi, Michela , Wyss-Coray, Tony , Bakula, Daniela , Tyshkovskiy, Alexander , Cuervo, Ana M , Seluanov, Andrei , Murray, Anna , Pedersen, Bente Klarlund , Schumacher, Björn , Kennedy, Brian Keith , Suetta, Charlotte , Kuppe, Christoph , Ewald, Collin Y. , Valenzano, Dario Riccardo , Rudnic, Edward M., Teeling, Emma C. , Verdin, Eric , Fang, Evandro Fei , Fagagna, Fabrizio d’Adda di , Galkin, Fedor , Jasper, Heinrich , Jang, In Hwa , Han, Jing‐Dong J. , Justice, Jamie N. , Hoeijmakers, Jan H.J. , Ramos, Javier María Peralta , Lemaı̂tre, Jean-Marc , Aerssens, Jeroen , Belmonte, Juan Carlos Izpisúa , Abdelmohsen, Kotb , Knudsen, Lotte Bjerre , Ferrucci, Luigi , Sylow, Lykke , Schafer, Marissa , Guasch‐Ferré, Marta , Levitt, Michael R. , Meldal, Morten , Fedichev, Peter O. , Mullen, Peter J. , Cabo, Rafael de, Houtkooper, Riekelt H. , Smith, Ryan , Rosenzweig‐Lipson, Sharon, Horvath, Steve , Rando, Thomas A. , White, Todd, Tammela, Tuomas , Gladyshev, Vadim N. , Sinatti, Vanessa V C , Liu, Xiaodong , Suh, Yousin , Koch, Zane , Zhavoronkov, Alex , Scheibye‐Knudsen, Morten

Mayo Clinic

Aging | April 6, 2026 | Volume: 18 | Issue: 1 | Pages: 282-302

10.18632/aging.206368 | PMID 41944812 Get It

Identification of the Novel HLA ‐ DQB1 Allele, DQB1*02:02:01:28Q , With a Mutation in the Intron 3 Donor Sp
Zhu, Hua , Robinson, T.L., Garabiles, Eric D., Elrefaei, Mohamed , Du, Zeying , Robinson, Terrence K, Robinson, Terrence K., Du, Zeying

Mayo Clinic

HLA | April 6, 2026 | Volume: 107 | Issue: 4 | Pages: No page available

10.1111/tan.70703 | PMID 41937712 Get It

ABSTRACT The novel HLA‐DQB1*02:02:01:28Q shows a point mutation in the intron 3 splice site.
Robotic-Assisted Single-Position Lateral Mini-Open Upper Lumbar Corpectomy with Posterior Percutaneous Pedicle Screw Fixation: A Technical Note with Illustrative Case Series
Iyer, Harshvardhan , Llano, Juan P. Navarro-Garcia de, Wang, Eric, Johnson, Walter R., Sastry, Rahul A. , Ramos, Rafael de La Garza, Sampath, Prakash , Gokaslan, Ziya L., Oyelese, Adetokunbo A. , Ramos, Rafael De la Garza , Llano, Juan P Navarro-Garcia de , De la Garza Ramos, Rafael , Navarro-Garcia de Llano, Juan P , Iyer, Harshvardhan G , Wang, Elaina J., Gokaslan, Ziya L., Akinduro, Oluwaseun O.

Mayo Clinic

Applied Sciences | April 6, 2026 | Volume: 16 | Issue: 7 | Pages: 3501

10.3390/app16073501 Get It

Management of unstable upper lumbar fractures with corpectomy and posterior fixation is technically demanding, and conventional workflows may require intraoperative repositioning, increasing operative complexity. Lateral mini-open upper lumbar corpectomy (LMULC) paired with robotic-assisted (RA) posterior percutaneous pedicle screw fixation (PPPSF) can be performed in a single position to facilitate ventral spinal decompression and stabilization in the anatomically constrained upper lumbar spine. In this study, we describe the operative technique and report four illustrative cases of unstable L1 or L2 fractures treated with single-position LMULC, RA-PPPSF, and short-segment fusion. Clinical, radiological, intraoperative variables and postoperative outcomes were evaluated. The mean age was 52.3 ± 17.7 years. The median operation time was 314 min (range 268–361 min); the median estimated blood loss (EBL) was 225 mL (range 100–400 mL). The median preoperative kyphosis was 10.15° (range 8.4–14.6°), the median postoperative kyphosis measured 6.65° (range 1.7–10.8°) and the median correction achieved was 3.5° (range −2.4–12.9°). The median visual analog scale (VAS) pain score reduced from 7 (range 7–9) preoperatively to 4.5 (range 2–6) postoperatively at discharge. At a median follow-up of 12 months (range 6–15 months), all patients had uncomplicated recoveries, demonstrated solid fusion on imaging, and reported favorable MacNab outcomes. Single-position LMULC with RA-PPPSF was technically feasible in this preliminary illustrative series and resulted in favorable clinical and radiographic outcomes. However, further studies in larger cohorts are warranted to help confirm these findings and better define the potential advantages and limitations of this technique.
The longevity effects of reduced IGF-1 signaling depend on the stability of the mitochondrial genome
Shemtov, Sarah J. , McGann, Eric, Carrillo, Lucy , Lee, Sangmin , Anson, Herbert, Chung, Claire S, Weinert, Jaye L., Anagnostou, Maria-Eleni, Lai, Guan-Ju, Verheijen, Bert M. , Wan, Junxiang , Vorobyova, Ivetta, Sanchez-Contreras, Monica, Conover, Cheryl A. , Thorwald, Max A. , Cohen, P., Kennedy, Scott R. , Goût, Jean-François , Haroon, Suraiya , Vermulst, Marc , Hwang, Eric , Chung, Claire S , Weinert, Jaye L , Lai, Guan-Ju D , Conover, Cheryl A , Thorwald, Max A , Cohen, Pinchas , Kennedy, Scott R , Gout, Jean-François , Vermulst, Marc , Anagnostou, Maria‐Eleni, Sánchez-Contreras, Mónica , Cohen, Pinchas

Mayo Clinic

Science Advances | April 3, 2026 | Volume: 12 | Issue: 14 | Pages: No page available

10.1126/sciadv.aea4279 | PMID 41931604 Get It

Suppression of insulin-like growth factor-1 (IGF-1) signaling extends mammalian life span and protects against a range of age-related diseases. Unexpectedly, we found that reduced IGF-1 signaling fails to extend the life span of mitochondrial mutator mice. Most of the longevity pathways that are normally initiated by IGF-1 suppression were either blocked or blunted in the mutator mice. These observations suggest that the prolongevity effects of IGF-1 suppression critically depend on the integrity of the mitochondrial genome, revealing an unexpected hierarchy in the pathways that control mammalian aging. Together, these findings deepen our understanding of the interactions between the hallmarks of aging and underscore the need for interventions that preserve the integrity of the mitochondrial genome.